Fingerprint
Dive into the research topics of 'Cases of ROS1-rearranged lung cancer: When to use crizotinib, entrectinib, lorlatinib, and beyond?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cases of ROS1-rearranged lung cancer: When to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations